FINNENCE ▪ THE WIRE FILE
THE WIRE · № 59940
News■ Unclear/unknown
Healthcare Supply Chain Management Market worth $5.31 billion by 2031
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-01 14:30 UTC
LAST UPDATE2026-10-01 14:30 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Modest 5.1% CAGR forecast for healthcare supply chain software implies steady but unspectacular demand.
Low-growth forecast, limited market catalyst
CATALYST TO WATCH
Vendor earnings confirming the trend
MAIN RISK
Forecast is vendor-sponsored research
FULL DISPATCH
DELRAY BEACH, Fla., Oct. 1, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Healthcare Supply Chain Management Market is projected to reach USD 5.31 billion by 2031 from USD 4.13 billion in 2026, at a CAGR of 5.1% during the forecast period. Browse 300 market data Tables and 100...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
CONTEXTHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Parakeet Health Raises $10 Million Series A Following 10x Growth and Rapid Enterprise Adoption2026-10-01 14:30 UTC
Parakeet Health Raises $10 Million Series A Following 10x Growth and Rapid Enterprise Adoption2026-10-01 14:30 UTC
→CORRELATIONshares Healthcare
Fabry Disease Market Outlook: 6 Upcoming Therapies Set to Influence the Future Market Landscape2026-10-01 14:31 UTC
Fabry Disease Market Outlook: 6 Upcoming Therapies Set to Influence the Future Market Landscape2026-10-01 14:31 UTC
→CORRELATIONshares Healthcare
Blue Shield of California Expands Medicare Offerings for 2027 with New Plans, Enhanced Benefits, and Digital Tools2026-10-01 15:02 UTC
Blue Shield of California Expands Medicare Offerings for 2027 with New Plans, Enhanced Benefits, and Digital Tools2026-10-01 15:02 UTC
←CORRELATIONshares Healthcare
Renew Biotechnologies Enters Collaboration to Evaluate NeuroLens® in Multiple Sclerosis and Related Neuroimmunologic Diseases2026-10-01 11:17 UTC
Renew Biotechnologies Enters Collaboration to Evaluate NeuroLens® in Multiple Sclerosis and Related Neuroimmunologic Diseases2026-10-01 11:17 UTC
←CORRELATIONshares Healthcare
New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 20262026-10-01 11:30 UTC
New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 20262026-10-01 11:30 UTC
←CORRELATIONshares Healthcare
Codoxo Awarded on TIME's List of the World's Top HealthTech Companies 20262026-10-01 12:01 UTC
Codoxo Awarded on TIME's List of the World's Top HealthTech Companies 20262026-10-01 12:01 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.